PANNACCI, MARILOU
PANNACCI, MARILOU
Dipartimento di Biotecnologie Mediche e Medicina Traslazionale
Incidence and risk factors of neurosurgical site infections : results of a prospective multicenter cohort study on 6359 surgeries
2021 L. Valentini, F. Chiaffarino, N. Bonfanti, M. Pannacci, P. Cortellazzi, C. Uberti-Foppa, M. Furlanetto, F. Di Meco, L. Massimi
Comparison of the potency of 10 different brands of Serenoa repens extracts
2012 F. Scaglione, V. Lucini, M. Pannacci, S. Dugnani, C. Leone
In vitro and in vivo pharmacokinetic/pharmacodynamic activity of clofoctol
2012 F. Scaglione, S. Dugnani, V. Lucini, M. Pannacci, L. Paraboni
Bivalent ligand approach on N-{2-[(3-methoxyphenyl)methylamino]ethyl}acetamide : synthesis, binding affinity and intrinsic activity for MT1 and MT2 melatonin receptors
2011 G. Spadoni, A. Bedini, P. Orlando, S. Lucarini, G. Tarzia, M. Mor, S. Rivara, V. Lucini, M. Pannacci, F. Scaglione
Toward the definition of stereochemical requirements for MT2-selective antagonists and partial agonists by studying 4-phenyl-2-propionamidotetralin derivatives
2011 A. Bedini, S. Lucarini, G. Spadoni, G. Tarzia, F. Scaglione, S. Dugnani, M. Pannacci, V. Lucini, C. Carmi, D. Pala, S. Rivara, M. Mor
Design, synthesis, and pharmacological effects of structurally simple ligands for MT1 and MT2 melatonin receptors
2010 A. Carocci, A. Catalano, A. Lovece, G. Lentini, A. Duranti, V. Lucini, M. Pannacci, F. Scaglione, C. Franchini
N-(Anilinoethyl)amides: design and synthesis of metabolically stable, selective melatonin receptor ligands
2009 S. Rivara, F. Vacondio, A. Fioni, C. Silva, C. Carmi, M. Mor, V. Lucini, M. Pannacci, A. Caronno, F. Scaglione, G. Gobbi, G. Spadoni, A. Bedini, P. Orlando, S. Lucarini, G. Tarzia
Comparison of the potency of different brands of serenoa repens extract on 5alpha-reductase types I and II in prostatic co-cultured epithelial and fibroblast cells
2008 F. Scaglione, V. Lucini, M. Pannacci, A. Caronno, C. Leone
Synthesis and the biological activity of new melatonin dimeric derivatives
2007 B. Di Giacomo, A. Bedini, G. Spadoni, G. Tarzia, F. Fraschini, M. Pannacci, V. Lucini
Synthesis, enantiomeric resolution, and structure-activity relationship study of a series of 10,11-dihydro-5H-dibenzo[a,d]cycloheptene MT2 receptor antagonists
2007 G. Spadoni, A. Bedini, G. Diamantini, G. Tarzia, S. Rivara, S. Lorenzi, A. Lodola, M. Mor, V. Lucini, M. Pannacci, A. Caronno, F. Fraschini
N-(substituted-anilinoethyl)amides: design, synthesis, and pharmacological characterization of a new class of melatonin receptor ligands
2007 S. Rivara, A. Lodola, M. Mor, A. Bedini, G. Spadoni, V. Lucini, M. Pannacci, F.L. Fraschini, F. Scaglione, R.O. Sanchez, G. Gobbi, G. Tarzia
Customizing antiangiogenesis therapy toward vessel normalization results in a long-term glioma growth control
2006 L. Bello, F. Colleoni, S. Sangiorgi, V. Lucini, M. Pannacci, F. Acerbi, C. Giussani, G. Carrabba, S. Gaini, A. Bikfalvi
Towards the development of mixed MT(1)-agonist/MT(2)-antagonist melatonin receptor ligands
2006 G. Spadoni, A. Bedini, T. Guidi, G. Tarzia, V. Lucini, M. Pannacci, F. Fraschini
Reassessing the melatonin pharmacophore-enantiomeric resolution, pharmacological activity, structure analysis, and molecular modeling of a constrained chiral melatonin analogue
2006 S. Rivara, G. Diamantini, B. Di Giacomo, D. Lamba, G. Gatti, V. Lucini, M. Pannacci, M. Mor, G. Spadoni, G. Tarzia
Tailoring of anti angiogenic therapies to tumor stage improves therapeutic efficacy in mouse models of human gliomas
2005 C. Giussani, F. Acerbi, S. Sangiorgi, F. Colleoni, G. Carrabba, V. Lucini, M. Pannacci, G. Tomei, S.M. Gaini, A. Bikfalvi, L. Bello
The standardised G115 Panax ginseng C.A. Meyer extract: a review of its properties and usage
2005 F. Scaglione, M. Pannacci, O. Petrini
Combinatorial administration of molecules that simultaneously inhibit angiogenesis and invasion leads to increased therapeutic efficacy in mouse models of malignant glioma
2004 L. Bello, V. Lucini, F. Costa, M. Pluderi, C.G. Giussani, F. Acerbi, G.G. Carrabba, M. Pannacci, D. Caronzolo, S. Grosso, S. Shinkaruk, F. Colleoni, X. Canron, G. Tomei, G. Deleris, A. Bikfalvi
Three-dimensional quantitative structure-activity relationship studies on selected MT1 and MT2 melatonin receptor ligands : requirements for subtype selectivity and intrinsic activity modulation
2003 S. Rivara, M. Mor, C. Silva, V. Zuliani, F. Vacondio, G. Spadoni, A. Bedini, G. Tarzia, V. Lucini, M. Pannacci, F. Fraschini, P.V. Plazzi
Local intracerebral delivery of endogenous inhibitors by osmotic minipumps effectively suppresses glioma growth in vivo
2003 C. Giussani, G. Carrabba, M. Pluderi, V. Lucini, M. Pannacci, D. Caronzolo, F. Costa, M. Minotti, G. Tomei, R. Villani, R.S. Carroll, A. Bikfalvi, L. Bello
Synthesis, pharmacological characterization and QSAR studies on 2-substituted indole melatonin receptor ligands
2001 M. Mor, G. Spadoni, B. Di Giacomo, G. Diamantini, A. Bedini, G. Tarzia, P.V. Plazi, S. Rivara, R. Nonno, V. Lucini, M. Pannacci, F. Fraschini, B.M. Stankov